Haleon (HLN) Other financing activities (2021 - 2023)
Haleon (HLN) posted Other financing activities of -$98.1 million for Q4 2023, down 134.98% on a QoQ basis from $280.3 million in Q4 2022, and down 134.98% year-over-year from $280.3 million in Q4 2022.
Haleon (HLN) Other financing activities (2021 - 2023) Analysis & Trends
Haleon's Other financing activities history runs 3 years deep, the most recent figure standing at -$98.1 million for Q4 2023.
- Quarterly Other financing activities fell 134.98% year-over-year to -$98.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $384.9 million (changed N/A YoY) and the FY2025 annual result came in at $40.9 million, up 499.7% from the prior year.
- Other financing activities was -$98.1 million for Q4 2023 at Haleon, down from $280.3 million in the prior quarter.
- Across five years, Other financing activities topped out at $294.3 million in Q3 2022 and bottomed at -$98.1 million in Q4 2023.
- A 3-year average of $96.2 million and a median of $94.3 million in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities surged 405.82% — and 2023, when it sank 134.98%.
- Haleon's Other financing activities stood at -$91.7 million in 2021, then jumped by 405.82% to $280.3 million in 2022, then plunged by 134.98% to -$98.1 million in 2023.
- Business Quant data shows HLN's Other financing activities at -$98.1 million in Q4 2023, $280.3 million in Q4 2022, and $294.3 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -98.05 Mn |
| Dec 31, 2023 | -98.05 Mn |
| Dec 31, 2022 | 280.33 Mn |
| Dec 31, 2022 | 280.33 Mn |
| Sep 20, 2022 | 294.28 Mn |
| Sep 20, 2022 | 294.28 Mn |
| Dec 31, 2021 | -91.66 Mn |
| Dec 31, 2021 | -91.66 Mn |